drugset / Trial / NCT00445887

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

NCT00445887

RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial is studying how well levonorgestrel works in preventing ovarian cancer in patients at high risk for ovarian cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of levonorgestrel may prevent ovarian cancer.

Timeline

Start
2008-03-10
Primary completion
2013-12-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule Oral

Indications